282 related articles for article (PubMed ID: 32151270)
21. Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
Tang CC; Holtbernd F; Ma Y; Spetsieris P; Oh A; Fink GR; Timmermann L; Eggers C; Eidelberg D
J Parkinsons Dis; 2020; 10(4):1737-1749. PubMed ID: 32925097
[TBL] [Abstract][Full Text] [Related]
22. Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients.
Horvath S; Ritz BR
Aging (Albany NY); 2015 Dec; 7(12):1130-42. PubMed ID: 26655927
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Regulation of Neuroinflammation in Parkinson's Disease.
Rasheed M; Liang J; Wang C; Deng Y; Chen Z
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066949
[TBL] [Abstract][Full Text] [Related]
24. Neuronal methylome reveals CREB-associated neuro-axonal impairment in multiple sclerosis.
Kular L; Needhamsen M; Adzemovic MZ; Kramarova T; Gomez-Cabrero D; Ewing E; Piket E; Tegnér J; Beck S; Piehl F; Brundin L; Jagodic M
Clin Epigenetics; 2019 May; 11(1):86. PubMed ID: 31146783
[TBL] [Abstract][Full Text] [Related]
25. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells.
Kaut O; Schmitt I; Tost J; Busato F; Liu Y; Hofmann P; Witt SH; Rietschel M; Fröhlich H; Wüllner U
Neurogenetics; 2017 Jan; 18(1):7-22. PubMed ID: 27709425
[TBL] [Abstract][Full Text] [Related]
26. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes.
Masliah E; Dumaop W; Galasko D; Desplats P
Epigenetics; 2013 Oct; 8(10):1030-8. PubMed ID: 23907097
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.
Elstner M; Morris CM; Heim K; Bender A; Mehta D; Jaros E; Klopstock T; Meitinger T; Turnbull DM; Prokisch H
Acta Neuropathol; 2011 Jul; 122(1):75-86. PubMed ID: 21541762
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease is associated with DNA methylation levels in human blood and saliva.
Chuang YH; Paul KC; Bronstein JM; Bordelon Y; Horvath S; Ritz B
Genome Med; 2017 Aug; 9(1):76. PubMed ID: 28851441
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson's disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity.
Go RCP; Corley MJ; Ross GW; Petrovitch H; Masaki KH; Maunakea AK; He Q; Tiirikainen MI
BMC Neurosci; 2020 Jul; 21(1):31. PubMed ID: 32650713
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways.
Schaffner SL; Wassouf Z; Lazaro DF; Xylaki M; Gladish N; Lin DTS; MacIsaac J; Ramadori K; Hentrich T; Schulze-Hentrich JM; Outeiro TF; Kobor MS
Hum Mol Genet; 2022 Oct; 31(21):3694-3714. PubMed ID: 35567546
[TBL] [Abstract][Full Text] [Related]
32. Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?
Lanore A; Lesage S; Mariani LL; Menon PJ; Ravassard P; Cheval H; Corti O; Brice A; Corvol JC
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328033
[TBL] [Abstract][Full Text] [Related]
33. Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
Fernández-Santiago R; Carballo-Carbajal I; Castellano G; Torrent R; Richaud Y; Sánchez-Danés A; Vilarrasa-Blasi R; Sánchez-Pla A; Mosquera JL; Soriano J; López-Barneo J; Canals JM; Alberch J; Raya Á; Vila M; Consiglio A; Martín-Subero JI; Ezquerra M; Tolosa E
EMBO Mol Med; 2015 Dec; 7(12):1529-46. PubMed ID: 26516212
[TBL] [Abstract][Full Text] [Related]
34. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
[TBL] [Abstract][Full Text] [Related]
35. Divergent neuronal DNA methylation patterns across human cortical development reveal critical periods and a unique role of CpH methylation.
Price AJ; Collado-Torres L; Ivanov NA; Xia W; Burke EE; Shin JH; Tao R; Ma L; Jia Y; Hyde TM; Kleinman JE; Weinberger DR; Jaffe AE
Genome Biol; 2019 Sep; 20(1):196. PubMed ID: 31554518
[TBL] [Abstract][Full Text] [Related]
36. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.
Kaut O; Kuchelmeister K; Moehl C; Wüllner U
J Chem Neuroanat; 2019 Mar; 96():41-48. PubMed ID: 30557654
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities.
Ammal Kaidery N; Tarannum S; Thomas B
Neurotherapeutics; 2013 Oct; 10(4):698-708. PubMed ID: 24030213
[TBL] [Abstract][Full Text] [Related]
39. Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere.
Claassen DO; McDonell KE; Donahue M; Rawal S; Wylie SA; Neimat JS; Kang H; Hedera P; Zald D; Landman B; Dawant B; Rane S
Brain Behav; 2016 Dec; 6(12):e00573. PubMed ID: 28031997
[TBL] [Abstract][Full Text] [Related]
40. Epigenetics in Parkinson's Disease.
Pavlou MAS; Outeiro TF
Adv Exp Med Biol; 2017; 978():363-390. PubMed ID: 28523556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
